This is the Guardian. This summer see the European box office smash that critics aren't raving about

The count of Monte Cristo is timeless and thrillingly new. Five-star says total film.

Rotten tomatoes rates it at 100%. It's a big exciting swashbuckling

adventure stunning, a genuine triumph based on Alexander Dumas's classic tale.

A few count of his life. The Count of Monte Cristo, in Cinema's now, certificate 12A. You're sat on the sofa at home watching TV and suddenly. A heat starts to radiate from the center of your chest.

You begin to sweat, and the heat travels up your neck.

You go red. There's sweat coming out of your scalp, the crooks of your elbows, trickling down your back.

It's a hot flush, or flash, and all you can do is wait it out.

For people going through menopause, this will probably be a very familiar sensation

and for many hot flushes can be hugely disruptive and

unpleasant but last week the Food and Drug Administration in the US approved

Fezolentent, a first of its kind non-harmonal

drug to treat hot flushes by targeting what's happening in the brain.

The drug could also be appraised by the National Institute for Health and Care Excellence in the UK by the end of this year.

It's an intriguing advance in the treatment of menopausal symptoms.

So today we're asking, what's going on in the brain to cause hot flushes?

How does this new medication work? And how much of a difference could it make?

From the Guardian, I'm Madeline Finley,

and this is Science Weekly.

Before we start, in this episode we'll be using the words woman and women to refer to people experiencing menopause, while acknowledging that not all people who go

through menopause will identify as women, and not all people who identify as women will

go through the menopause.

...